Market Cap

Viridian Therapeutics, Inc. Market Capitalization:

$2.93 Billion

USD as of Jan. 1, 2026

business Viridian Therapeutics, Inc. Company Profile

Viridian Therapeutics, Inc. Main Stock Listing

NASDAQ: VRDN

Market Capitalization History of Viridian Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Viridian Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $2.93 B 94.25%
Jan. 1, 2025 $1.51 B 35.09%
Jan. 1, 2024 $1.12 B -26.22%
Jan. 1, 2023 $1.51 B 86.97%
Jan. 1, 2022 $809.0 M 12.79%
Jan. 1, 2021 $717.2 M -32.11%
Jan. 1, 2020 $1.06 B -38.81%
Jan. 1, 2019 $1.73 B -61.87%
Jan. 1, 2018 $4.53 B -17.31%
Jan. 1, 2017 $5.48 B 9.94%
Jan. 1, 2016 $4.98 B -79.73%
Jan. 1, 2015 $24.58 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Viridian Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Viridian Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: VRDN

Stock: FSX: 1S1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.